Media

Swiss RTS television reportage on innovation and denovoCast

More than a year since CUTISS announced the world’s first machine to bioengineer human skin, the news continues to generate interest and excitement. As part of their program focused on Swiss innovation, the broadcaster RTS (Neuchatel) visited CUTISS and CSEM who helped develop the denovoCast machine, to find out how automation can scale-up the production …

Swiss RTS television reportage on innovation and denovoCast Read More »

Tribune de Côte d’Azur reports on CUTISS Innovation

The Tribune de Côte d’Azur covered the first ‘Impact Awards’ 2022, a jury-led competition organized by Team Côte d’Azur that recognizes leading companies of the local economic ecosystem. CUTISS Innovation, our French subsidiary, was honored to win the ‘Innovation’ trophy for continued innovation and research into regenerative medicine and skin pigmentation. Our director Cécile Cousin was …

Tribune de Côte d’Azur reports on CUTISS Innovation Read More »

Agefi reports on the start of on-site production

The Swiss daily business newspaper Agefi published an interview with our CEO Daniela Marino following the announcement that CUTISS started onsite denovoSkin production, at its very own GMP facility. This is an exciting milestone for the company, resulting in greater production flexibility and scale-up opportunities. Newsroom Link to Interview

Sciences et Avenir: A machine produces personalized skin

The popular French science magazine Sciences et Avenir has published an article explaining the science behind our denovoSkin and denovoCast innovations, and the promise that this brings to patients suffering from severe skin burns and injuries. The journalist had visited CUTISS to see this for herself and to speak with our CEO Daniela and CIO Vincent. “Swiss …

Sciences et Avenir: A machine produces personalized skin Read More »

Journal of Wound Care: The future of bioengineering personalized skin

As part of the journal’s “Innovations in wound care” section, the latest edition features a guest editorial by our CEO Daniela Marino and CIO Vincent Ronfard. When patients suffer from large and severe skin injuries affecting more than 50% of the body, such as burns, then the current standard of care – autografting – presents …

Journal of Wound Care: The future of bioengineering personalized skin Read More »

Scroll to Top

Newsletter

Would you like to contact us as a journalist?

©WyssZurich

This website uses cookies to ensure you get the best experience on our website.